Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer

Phase 1 Zymeworks ovarian cancer data show strong anti-tumor activity for ZW191 in heavily pretreated patients. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real